Sebastian G Schneeweiss (Sebastian Schneeweiss)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 78

Top Topics

Oral Anticoagulants

Atrial Fibrillation

Top Venues

Pharmacoepidemiology and drug safety

Clinical pharmacology and therapeutics

Clinical epidemiology

Annals of internal medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Kueiyu Joshua Lin, Daniel E Singer, Jerry Avorn, Edwin Kevin Heist, Sushama Kattinakere Sreedhara, Priyanka Anand, Yichi Zhang, Theodore N Tsacogianis, Sebastian G Schneeweiss
Patient Characteristics Associated With Using Transcatheter Left Atrial Appendage Occlusion Versus Oral Anticoagulants for Atrial Fibrillation. Circulation. Cardiovascular quality and outcomes (2024)
John Tazare, Shirley V Wang, Rosa Gini, Daniel Prieto Alhambra, Peter Arlett, Daniel R Morales Leaver, Caroline Morton, John Logie, Jennifer Popovic, Katherine Donegan, Sebastian G Schneeweiss, Ian Douglas, Anna Schultze
Sharing Is Caring? International Society for Pharmacoepidemiology Review and Recommendations for Sharing Programming Code. Pharmacoepidemiology and drug safety 33 (9) (2024)
Shirley V Wang, Kueiyu Joshua Lin, Sebastian G Schneeweiss
Emulation of randomized trials of direct oral anticoagulants with claims data and implications for new Factor XI inhibitors. Pharmacoepidemiology and drug safety 33 (5) (2024)
Rachel Heyard, Leonhard Held, Sebastian G Schneeweiss, Shirley V Wang
Design differences and variation in results between randomised trials and non-randomised emulations: meta-analysis of RCT-DUPLICATE data. BMJ medicine 3 (1) (2024)
Rachel Heyard, Leonhard Held, Sebastian G Schneeweiss, Shirley V Wang
Design differences and variation in results between randomised trials and non-randomised emulations: meta-analysis of RCT-DUPLICATE data. BMJ medicine 3 (1) (2024)
Phyo Than Htoo, Helen Tesfaye, Sebastian G Schneeweiss, Deborah J Wexler, Brendan M Everett, Robert J Glynn, Niklas Schmedt, Lisette Koeneman, Anouk Déruaz-Luyet, Julie M Paik, Elisabetta Patorno
Effectiveness and safety of empagliflozin: final results from the EMPRISE study. Diabetologia (2024)
Kueiyu Joshua Lin, Daniel E Singer, Jerry Avorn, Edwin Kevin Heist, Sushama Kattinakere Sreedhara, Priyanka Anand, Yichi Zhang, Theodore N Tsacogianis, Sebastian G Schneeweiss
Patient Characteristics Associated With Using Transcatheter Left Atrial Appendage Occlusion Versus Oral Anticoagulants for Atrial Fibrillation. Circulation. Cardiovascular quality and outcomes 17 (3) (2024)
Kueiyu Joshua Lin, Daniel E Singer, Jerry Avorn, Edwin Kevin Heist, Sushama Kattinakere Sreedhara, Priyanka Anand, Yichi Zhang, Theodore N Tsacogianis, Sebastian G Schneeweiss
Patient Characteristics Associated With Using Transcatheter Left Atrial Appendage Occlusion Versus Oral Anticoagulants for Atrial Fibrillation. Circulation. Cardiovascular quality and outcomes 17 (3) (2024)
Rachel Heyard, Leonhard Held, Sebastian G Schneeweiss, Shirley V Wang
Design differences and variation in results between randomised trials and non-randomised emulations: meta-analysis of RCT-DUPLICATE data. BMJ medicine 3 (1) (2024)
Rachel Heyard, Leonhard Held, Sebastian G Schneeweiss, Shirley V Wang
Design differences and variation in results between randomised trials and non-randomised emulations: meta-analysis of RCT-DUPLICATE data. BMJ medicine 3 (1) (2024)
Phyo Than Htoo, Helen Tesfaye, Sebastian G Schneeweiss, Deborah J Wexler, Brendan M Everett, Robert J Glynn, Niklas Schmedt, Lisette Koeneman, Anouk Déruaz-Luyet, Julie M Paik, Elisabetta Patorno
Effectiveness and safety of empagliflozin: final results from the EMPRISE study. Diabetologia 67 (7) (2024)
Maria C Schneeweiss, Arash Mostaghimi, Stephanie E Chiuve, Sebastian G Schneeweiss, Priyanka Anand, Katharina Schoder, Theresa Oduol, Carrie Huisingh, Kueiyu Joshua Lin
Validation of alopecia coding in US claims data among women of childbearing age. Pharmacoepidemiology and drug safety 33 (4) (2024)
Shirley V Wang, Kueiyu Joshua Lin, Sebastian G Schneeweiss
Emulation of randomized trials of direct oral anticoagulants with claims data and implications for new Factor XI inhibitors. Pharmacoepidemiology and drug safety 33 (5) (2024)
Shirley V Wang, Kueiyu Joshua Lin, Sebastian G Schneeweiss
Emulation of randomized trials of direct oral anticoagulants with claims data and implications for new Factor XI inhibitors. Pharmacoepidemiology and drug safety 33 (5) (2024)
Kueiyu Joshua Lin, Daniel E Singer, Jerry Avorn, Edwin Kevin Heist, Sushama Kattinakere Sreedhara, Priyanka Anand, Yichi Zhang, Theodore N Tsacogianis, Sebastian G Schneeweiss
Patient Characteristics Associated With Using Transcatheter Left Atrial Appendage Occlusion Versus Oral Anticoagulants for Atrial Fibrillation. Circulation. Cardiovascular quality and outcomes 17 (3) (2024)
Maria C Schneeweiss, Arash Mostaghimi, Stephanie E Chiuve, Sebastian G Schneeweiss, Priyanka Anand, Katharina Schoder, Theresa Oduol, Carrie Huisingh, Kueiyu Joshua Lin
Validation of alopecia coding in US claims data among women of childbearing age. Pharmacoepidemiology and drug safety 33 (4) (2024)
Kueiyu Joshua Lin, Daniel E Singer, Jerry Avorn, Edwin Kevin Heist, Sushama Kattinakere Sreedhara, Priyanka Anand, Yichi Zhang, Theodore N Tsacogianis, Sebastian G Schneeweiss
Patient Characteristics Associated With Using Transcatheter Left Atrial Appendage Occlusion Versus Oral Anticoagulants for Atrial Fibrillation. Circulation. Cardiovascular quality and outcomes 17 (3) (2024)
Sebastian G Schneeweiss
Enhancing External Control Arm Analyses through Data Calibration and Hybrid Designs. Clinical pharmacology and therapeutics (2024)
Julien Kirchgesner, Shirley V Wang, Sebastian G Schneeweiss
Strengthening Real-World Evidence on Question Not Answered by Randomized Trials: A Trial Calibration Approach. Pharmacoepidemiology and drug safety 33 (9) (2024)
Shirley V Wang, Kueiyu Joshua Lin, Sebastian G Schneeweiss
Emulation of randomized trials of direct oral anticoagulants with claims data and implications for new Factor XI inhibitors. Pharmacoepidemiology and drug safety 33 (5) (2024)
Phyo Than Htoo, Robert J Glynn, Shirley V Wang, Julie M Paik, Sebastian G Schneeweiss, Alexander Muir Walker, Elisabetta Patorno
Stratified analysis in comparative effectiveness studies that emulate randomized trials. Pharmacoepidemiology and drug safety (2023)
Rachel Heyard, Leonhard Held, Sebastian G Schneeweiss, Shirley V Wang
Design differences explain variation in results between randomized trials and their non-randomized emulations. medRxiv : the preprint server for health sciences (2023)
Tracey G Simon, Sebastian G Schneeweiss, Daniel E Singer, Sushama Kattinakere Sreedhara, Kueiyu Joshua Lin
Prescribing Trends of Oral Anticoagulants in US Patients With Cirrhosis and Nonvalvular Atrial Fibrillation. Journal of the American Heart Association 12 (3) (2023)
Tracey G Simon, Sebastian G Schneeweiss, Daniel E Singer, Sushama Kattinakere Sreedhara, Kueiyu Joshua Lin
Prescribing Trends of Oral Anticoagulants in US Patients With Cirrhosis and Nonvalvular Atrial Fibrillation. Journal of the American Heart Association 12 (3) (2023)
HoJin Shin, Shirley V Wang, Dae Hyun Kim, Ethan Alt, Mufaddal Mahesri, Lily G Bessette, Sebastian G Schneeweiss, Mehdi Najafzadeh
Predicting treatment effects of a new-to-market drug in clinical practice based on phase III randomized trial results. Clinical pharmacology and therapeutics (2023)
Richard Wyss, Joseph M Plasek, Li Zhou, Lily G Bessette, Sebastian G Schneeweiss, Jeremy A Rassen, Theodore Tsacogianis, Kueiyu Joshua Lin
Scalable Feature Engineering from Electronic Free Text Notes to Supplement Confounding Adjustment of Claims-Based Pharmacoepidemiologic Studies. Clinical pharmacology and therapeutics 113 (4) (2023)
Tracey G Simon, Sebastian G Schneeweiss, Daniel E Singer, Sushama Kattinakere Sreedhara, Kueiyu Joshua Lin
Prescribing Trends of Oral Anticoagulants in US Patients With Cirrhosis and Nonvalvular Atrial Fibrillation. Journal of the American Heart Association (2023)
Richard Wyss, Joseph M Plasek, Li Zhou, Lily G Bessette, Sebastian G Schneeweiss, Jeremy A Rassen, Theodore Tsacogianis, Kueiyu Joshua Lin
Scalable Feature Engineering from Electronic Free Text Notes to Supplement Confounding Adjustment of Claims-Based Pharmacoepidemiologic Studies. Clinical pharmacology and therapeutics 113 (4) (2023)
Maria Kahn, Steffeni Papukchieva, Elizabeth Jacyshyn-Owen, Stefan Grimm, Markus Eberl, Sebastian G Schneeweiss, Marina Otten, Matthias Augustin, Benjamin Friedrich
The IMPACT of the COVID-19 Pandemic on Prescription Drug Use in Patients with Psoriasis Vulgaris in Germany. Dermatology and therapy (2023)
Mehdi NajafZadeh, HoJin Shin, Sebastian G Schneeweiss, Shirley V Wang, Scott D Solomon, Orly Vardeny, Elisabetta Patorno
High-dose vs. standard-dose influenza vaccine and cardiopulmonary hospitalization or mortality: emulating the INVESTED trial using insurance claims data. Clinical pharmacology and therapeutics (2023)
Tracey G Simon, Sebastian G Schneeweiss, Richard Wyss, Zhigang Lu, Lily G Bessette, Cassandra York, Kueiyu Joshua Lin
Development and Validation of a Novel Tool to Predict Model for End-Stage Liver Disease (MELD) Scores in Cirrhosis, Using Administrative Datasets. Clinical epidemiology 15 (2023)
Edouard L Fu, Elisabetta Patorno, Brendan M Everett, Muthiah Vaduganathan, Scott D Solomon, Raisa Levin, Sebastian G Schneeweiss, Rishi J Desai
Sodium-glucose cotransporter 2 inhibitors vs. sitagliptin in heart failure and type 2 diabetes: an observational cohort study. European heart journal (2023)
Tracey G Simon, Sebastian G Schneeweiss, Daniel E Singer, Sushama Kattinakere Sreedhara, Kueiyu Joshua Lin
Prescribing Trends of Oral Anticoagulants in US Patients With Cirrhosis and Nonvalvular Atrial Fibrillation. Journal of the American Heart Association 12 (3) (2023)
Tracey G Simon, Sebastian G Schneeweiss, Daniel E Singer, Sushama Kattinakere Sreedhara, Kueiyu Joshua Lin
Prescribing Trends of Oral Anticoagulants in US Patients With Cirrhosis and Nonvalvular Atrial Fibrillation. Journal of the American Heart Association 12 (3) (2023)
Tracey G Simon, Sebastian G Schneeweiss, Daniel E Singer, Sushama Kattinakere Sreedhara, Kueiyu Joshua Lin
Prescribing Trends of Oral Anticoagulants in US Patients With Cirrhosis and Nonvalvular Atrial Fibrillation. Journal of the American Heart Association 12 (3) (2023)
Tracey G Simon, Sebastian G Schneeweiss, Richard Wyss, Zhigang Lu, Lily G Bessette, Cassandra York, Kueiyu Joshua Lin
Development and Validation of a Novel Tool to Predict Model for End-Stage Liver Disease (MELD) Scores in Cirrhosis, Using Administrative Datasets. Clinical epidemiology 15 (2023)
HoJin Shin, Sebastian G Schneeweiss, Robert J Glynn, Elisabetta Patorno
Evolving channeling in prescribing SGLT-2 inhibitors as first-line treatment for type 2 diabetes. Pharmacoepidemiology and drug safety 31 (5) (2022)
Shirley V Wang, Jesper Hallas, William Crown, Peter Arlett, Darren M Ashcroft, Eric I Benchimol, Marc L Berger, Gracy Crane, Wim Goettsch, Wei Hua, Shaum Kabadi, David M Kern, Xavier Kurz, Sinead Langan, Takahiro Nonaka, Lucinda Orsini, Susanna Perez-Gutthann, Simone Pinheiro, Nicole L Pratt, Sebastian G Schneeweiss, Massoud Toussi, Rebecca J Williams
HARmonized Protocol Template to Enhance Reproducibility of hypothesis evaluating real-world evidence studies on treatment effects: A good practices report of a joint ISPE/ISPOR task force. Pharmacoepidemiology and drug safety (2022)
Richard Wyss, Joseph M Plasek, Li Zhou, Lily G Bessette, Sebastian G Schneeweiss, Jeremy A Rassen, Theodore Tsacogianis, Kueiyu Joshua Lin
Scalable feature engineering from electronic free text notes to supplement confounding adjustment of claims-based pharmacoepidemiologic studies. Clinical pharmacology and therapeutics (2022)
David Merola, Ulka Campbell, Nileesa Gautam, Alexa Rubens, Sebastian G Schneeweiss, Shirley V Wang, Gillis Carrigan, Victoria Chia, Osayi E Akinbosoye, Simone Pinheiro, Amanda Bruno, Xiaolong Jiao, Mark D Stewart, Rachele Hendricks-Sturrup, Carla Rodriguez-Watson, Sajan Khosla, Yiduo Zhang, Mothaffar Rimawi, Jenny Huang, Aliki Taylor, Lauren Becnel, Lynn McRoy, Joy Eckert, Benjamin Taylor
The Aetion Coalition to Advance Real-World Evidence through Randomized Controlled Trial Emulation Initiative: Oncology. Clinical pharmacology and therapeutics (2022)
Elisabetta Patorno, Phyo Than Htoo, Robert J Glynn, Sebastian G Schneeweiss, Deborah J Wexler, Ajinkya Pawar, Lily G Bessette, Kristyn Chin, Brendan M Everett, Seoyoung C Kim
Sodium-Glucose Cotransporter-2 Inhibitors Versus Glucagon-like Peptide-1 Receptor Agonists and the Risk for Cardiovascular Outcomes in Routine Care Patients With Diabetes Across Categories of Cardiovascular Disease. Annals of internal medicine 175 (1) (2022)
Nicolle M Gatto, Shirley V Wang, William Murk, Pattra Mattox, M Alan Brookhart, Andrew Bate, Sebastian G Schneeweiss, Jeremy A Rassen
Visualizations throughout pharmacoepidemiology study planning, implementation, and reporting. Pharmacoepidemiology and drug safety 31 (11) (2022)
David Merola, Jessica Young, Deborah Schrag, Kueiyu Joshua Lin, Sarah Alwardt, Sebastian G Schneeweiss
Effectiveness research in oncology with electronic health record data: A retrospective cohort study emulating the PALOMA-2 trial. Pharmacoepidemiology and drug safety (2022)
HoJin Shin, Sebastian G Schneeweiss, Robert J Glynn, Elisabetta Patorno
Cardiovascular Outcomes in Patients Initiating First-Line Treatment of Type 2 Diabetes With Sodium-Glucose Cotransporter-2 Inhibitors Versus Metformin : A Cohort Study. Annals of internal medicine 175 (7) (2022)
Rishi J Desai, Mufaddal Mahesri, Su Been Lee, Vijay R Varma, Tina Loeffler, Irene Schilcher, Tobias Gerhard, Jodi B Segal, Mary E Ritchey, Daniel B Horton, Seoyoung C Kim, Sebastian G Schneeweiss, Madhav Thambisetty
No association between initiation of phosphodiesterase-5 inhibitors and risk of incident Alzheimer's disease and related dementia: results from the Drug Repurposing for Effective Alzheimer's Medicines study. Brain communications 4 (5) (2022)
Santosh K Verma, Joanna Huang, Howard G Hutchinson, Irisdaly Estevez, Kammy Kuang, Shannon L Reynolds, Sebastian G Schneeweiss
Statin Use and Severe Acute Liver Injury Among Patients with Elevated Alanine Aminotransferase. Clinical epidemiology 14 (2022)
Jeremy A Rassen, Patrick Blin, Sebastian Kloss, Romain S Neugebauer, Robert W Platt, Jesper Hallas, Sebastian G Schneeweiss, Sengwee Toh
High-dimensional propensity scores for empirical covariate selection in secondary database studies: Planning, implementation, and reporting. Pharmacoepidemiology and drug safety (2022)
HoJin Shin, Sebastian G Schneeweiss, Robert J Glynn, Elisabetta Patorno
Cardiovascular Outcomes in Patients Initiating First-Line Treatment of Type 2 Diabetes With Sodium-Glucose Cotransporter-2 Inhibitors Versus Metformin. Annals of internal medicine 175 (12) (2022)
Priyanka Anand, Sebastian G Schneeweiss, Arash Mostaghimi, Maria C Schneeweiss
Use patterns of systemic immunomodulators in the United States before and after dupilumab approval in adults with atopic dermatitis. Pharmacoepidemiology and drug safety (2022)
David Merola, Jessica Young, Deborah Schrag, Kueiyu Joshua Lin, Nicholas Robert, Sebastian G Schneeweiss
Oncology Drug Effectiveness from Electronic Health Record Data Calibrated Against RCT Evidence: The PARSIFAL Trial Emulation. Clinical epidemiology 14 (2022)
Sebastian G Schneeweiss, Elisabetta Patorno
Conducting Real-world Evidence Studies on the Clinical Outcomes of Diabetes Treatments. Endocrine reviews 42 (5) (2022)
David Merola, Sebastian G Schneeweiss, Yinzhu Jin, Joyce Lii, Kueiyu Joshua Lin
Advancing an Algorithm for the Identification of Patients with High Data-Continuity in Electronic Health Records. Clinical epidemiology 14 (2022)
Priyanka Anand, Sebastian G Schneeweiss, Arash Mostaghimi, Maria C Schneeweiss
Use patterns of systemic immunomodulators in the United States before and after dupilumab approval in adults with atopic dermatitis. Pharmacoepidemiology and drug safety (2022)
Santosh K Verma, Joanna Huang, Howard G Hutchinson, Irisdaly Estevez, Kammy Kuang, Shannon L Reynolds, Sebastian G Schneeweiss
Statin Use and Severe Acute Liver Injury Among Patients with Elevated Alanine Aminotransferase. Clinical epidemiology 14 (2022)
HoJin Shin, Sebastian G Schneeweiss, Robert J Glynn, Elisabetta Patorno
Cardiovascular Outcomes in Patients Initiating First-Line Treatment of Type 2 Diabetes With Sodium-Glucose Cotransporter-2 Inhibitors Versus Metformin. Annals of internal medicine 175 (12) (2022)
Shirley V Wang, Sebastian G Schneeweiss
A Framework for Visualizing Study Designs and Data Observability in Electronic Health Record Data. Clinical epidemiology 14 (2022)
Richard Wyss, Joseph M Plasek, Li Zhou, Lily G Bessette, Sebastian G Schneeweiss, Jeremy A Rassen, Theodore Tsacogianis, Kueiyu Joshua Lin
Scalable Feature Engineering from Electronic Free Text Notes to Supplement Confounding Adjustment of Claims-Based Pharmacoepidemiologic Studies. Clinical pharmacology and therapeutics (2022)
John Tazare, Richard Wyss, Jessica M Franklin, Liam Smeeth, Stephen J W Evans, Shirley V Wang, Sebastian G Schneeweiss, Ian J Douglas, Joshua J Gagne, Elizabeth J Williamson
Transparency of high-dimensional propensity score analyses: Guidance for diagnostics and reporting. Pharmacoepidemiology and drug safety 31 (4) (2022)
Dae Hyun Kim, Ajinkya Pawar, Joshua J Gagne, Lily G Bessette, Hemin Lee, Robert J Glynn, Sebastian G Schneeweiss
Frailty and Clinical Outcomes of Direct Oral Anticoagulants Versus Warfarin in Older Adults With Atrial Fibrillation : A Cohort Study. Annals of internal medicine 174 (9) (2021)
Sebastian G Schneeweiss, Brian L Strom
Obituary: Professor Joerg Hasfrod. Pharmacoepidemiology and drug safety 30 (10) (2021)
Elisabetta Patorno, Phyo Than Htoo, Robert J Glynn, Sebastian G Schneeweiss, Deborah J Wexler, Ajinkya Pawar, Lily G Bessette, Kristyn Chin, Brendan M Everett, Seoyoung C Kim
Sodium-Glucose Cotransporter-2 Inhibitors Versus Glucagon-like Peptide-1 Receptor Agonists and the Risk for Cardiovascular Outcomes in Routine Care Patients With Diabetes Across Categories of Cardiovascular Disease. Annals of internal medicine 174 (11) (2021)
Julien Kirchgesner, Rishi J Desai, Maria C Schneeweiss, Laurent Beaugerie, Seoyoung C Kim, Sebastian G Schneeweiss
Emulation of a randomized controlled trial in ulcerative colitis with US and French claims data: Infliximab with thiopurines compared to infliximab monotherapy. Pharmacoepidemiology and drug safety (2021)
Jessica M Franklin, Kueiyu Joshua Lin, Nicolle M Gatto, Jeremy A Rassen, Robert J Glynn, Sebastian G Schneeweiss
Real-World Evidence for Assessing Pharmaceutical Treatments in the Context of COVID-19. Clinical pharmacology and therapeutics 109 (4) (2021)
Mustafa Hashmi, Jeremy A Rassen, Sebastian G Schneeweiss
Single-arm oncology trials and the nature of external controls arms. Journal of comparative effectiveness research 10 (12) (2021)
Jeremy A Rassen, William Murk, Sebastian G Schneeweiss
Reply to the Letter by Arterburn D. et al. ("Bias in EHR-based studies: Seeing the Forest for the Trees"). Diabetes, obesity & metabolism 23 (7) (2021)
Jeremy A Rassen, William Murk, Sebastian G Schneeweiss
Real-world evidence of bariatric surgery and cardiovascular benefits using electronic health records data: A lesson in bias. Diabetes, obesity & metabolism 23 (7) (2021)
Kevin Wing, Elizabeth J Williamson, James R Carpenter, Lesley Wise, Sebastian G Schneeweiss, Liam Smeeth, Jennifer Kathleen Quint, Ian J Douglas
Medications for chronic obstructive pulmonary disease: a historical non-interventional cohort study with validation against RCT results. Health technology assessment (Winchester, England) 25 (51) (2021)
Michael Fralick, Martin Kulldorff, Donald Redelmeier, Shirley V Wang, Seanna Vine, Sebastian G Schneeweiss, Elisabetta Patorno
A novel data mining application to detect safety signals for newly approved medications in routine care of patients with diabetes. Endocrinology, diabetes & metabolism 4 (3) (2021)
Sebastian G Schneeweiss, Samy Suissa
Discussion of Schuemie et al: "A plea to stop using the case-control design in retrospective database studies". Statistics in medicine 38 (22) (2020)
Krista F Huybrechts, Chandrasekar Gopalakrishnan, Dorothee B Bartels, Kristina Zint, Venkatesh K Gurusamy, Joan Landon, Sebastian G Schneeweiss
Safety and Effectiveness of Dabigatran and Other Direct Oral Anticoagulants Compared With Warfarin in Patients With Atrial Fibrillation. Clinical pharmacology and therapeutics 107 (6) (2020)
Moa P Lee, Robert J Glynn, Sebastian G Schneeweiss, Kueiyu Joshua Lin, Elisabetta Patorno, Julie Barberio, Raisa Levin, Thomas Evers, Shirley V Wang, Rishi J Desai
Risk Factors for Heart Failure with Preserved or Reduced Ejection Fraction Among Medicare Beneficiaries: Application of Competing Risks Analysis and Gradient Boosted Model. Clinical epidemiology 12 (2020)
Rick A Vreman, Huseyin Naci, Wim G Goettsch, Aukje K Mantel-Teeuwisse, Sebastian G Schneeweiss, Hubertus G Leufkens, Aaron S Kesselheim
Decision Making Under Uncertainty: Comparing Regulatory and Health Technology Assessment Reviews of Medicines in the United States and Europe. Clinical pharmacology and therapeutics 108 (2) (2020)
Katsiaryna Bykov, Sebastian G Schneeweiss, Robert J Glynn, Murray A Mittleman, Joshua J Gagne
A Case-Crossover-Based Screening Approach to Identifying Clinically Relevant Drug-Drug Interactions in Electronic Healthcare Data. Clinical pharmacology and therapeutics 106 (1) (2019)
Jessica M Franklin, Ajinkya M Pawar, David Martin, Robert J Glynn, Mark Levenson, Robert Temple, Sebastian G Schneeweiss
Nonrandomized Real-World Evidence to Support Regulatory Decision Making: Process for a Randomized Trial Replication Project. Clinical pharmacology and therapeutics 107 (4) (2019)
Jessica M Franklin, Robert J Glynn, David Martin, Sebastian G Schneeweiss
Evaluating the Use of Nonrandomized Real-World Data Analyses for Regulatory Decision Making. Clinical pharmacology and therapeutics 105 (4) (2019)
Michael Fralick, Sebastian G Schneeweiss, Christopher J D Wallis, Emily H Jung, Aaron S Kesselheim
Desmopressin and the risk of hyponatremia: A population-based cohort study. PLoS medicine 16 (10) (2019)
Shirley V Wang, Martin Kulldorff, Robert J Glynn, Joshua J Gagne, Jesper Hallas, Kenneth J Rothman, Sebastian G Schneeweiss, Alexander Muir Walker
Reuse of data sources to evaluate drug safety signals: When is it appropriate? Pharmacoepidemiology and drug safety 27 (6) (2018)
Krista F Huybrechts, Chandrasekar Gopalakrishnan, Jessica M Franklin, Kristina Zint, Lionel Riou Franca, Dorothee B Bartels, Joan Landon, Sebastian G Schneeweiss
Claims Data Studies of Direct Oral Anticoagulants Can Achieve Balance in Important Clinical Parameters Only Observable in Electronic Health Records. Clinical pharmacology and therapeutics 105 (4) (2018)